These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3427593)

  • 21. [A two-center study on the effects of silymarin in pregnant women and adult patients with so-called minor hepatic insufficiency].
    Giannola C; Buogo F; Forestiere G; Scaffidi L; Ferrigno V; Scaffidi A
    Clin Ter; 1985 Jul; 114(2):129-35. PubMed ID: 4053531
    [No Abstract]   [Full Text] [Related]  

  • 22. [Uses of silymarin in the treatment of symptomatic hepatic porphyria (author's transl)].
    Kordac V; Kaláb M
    Cas Lek Cesk; 1977 Apr; 116(13):407-10. PubMed ID: 861998
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study of the therapeutic action of silymarin in acute infectious hepatitis in childhood].
    Mingrino F; Tosti U; Anania S; Buglioni MC; Viola F
    Minerva Pediatr; 1979 Mar; 31(6):451-6. PubMed ID: 470888
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ambulatory treatment of hepatic damage: comparison of 2 therapeutic modalities].
    Ravetta A
    Clin Ter; 1981 Oct; 99(2):149-53. PubMed ID: 7318368
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of silymarin in intrahepatic cholestasis of pregnancy (preliminary communication)].
    Hernández R; Nazar E
    Rev Chil Obstet Ginecol; 1982; 47(1):22-9. PubMed ID: 6927150
    [No Abstract]   [Full Text] [Related]  

  • 26. [Silymarin in the treatment of acute viral hepatitis].
    Patera L
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):533-4. PubMed ID: 737788
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of a flavonoid on capillary resistance in liver cirrhosis].
    Wild C; Fasel J
    Praxis; 1967 May; 56(20):698-9. PubMed ID: 5633087
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of the administration of silymarin on serum lipid levels].
    Petronelli A; Roda E; Briganti M; Morselli Labate AM; Barbara L
    Clin Ter; 1981 Dec; 99(5):471-82. PubMed ID: 7333068
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ultrastructural morphometric investigations on mouse liver after treatment with phalloidin and alpha-amanitin followed by application of silybin (author's transl)].
    Meiss R; Brauch F; Themann H
    Z Gastroenterol; 1981 Aug; 19(8):384-9. PubMed ID: 7281857
    [No Abstract]   [Full Text] [Related]  

  • 30. [Alcoholic hepatopathy. Aspects of drug therapy].
    Del Dotto M; Neri D
    G Clin Med; 1982 Apr; 63(4):228-36. PubMed ID: 7128979
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of silymarin and SAMe in the treatment of acute infective hepatitis in childhood].
    Musso A; Giacchino M; Vietti M; Vaccino P; Cerutti A
    Minerva Pediatr; 1980 Sep; 32(17):1057-67. PubMed ID: 7453688
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxic occupational liver diseases. Therapeutic effects of silymarin].
    Boari C; Montanari FM; Galletti GP; Rizzoli D; Baldi E; Caudarella R; Gennari P
    Minerva Med; 1981 Oct; 72(40):2679-88. PubMed ID: 7290471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid.
    Muriel P; Moreno MG; Hernández Mdel C; Chávez E; Alcantar LK
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):375-80. PubMed ID: 15853930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Legalon in the complex treatment of patients with hepatic stasis in chronic circulatory insufficiency].
    Krylov AA
    Vrach Delo; 1984 Mar; (3):22-3. PubMed ID: 6719894
    [No Abstract]   [Full Text] [Related]  

  • 35. [Milk thistle (Silybum marianum) derivatives in the therapy of chronic hepatopathies].
    De Martiis M; Fontana M; Assogna G; D'Ottavi R; D'Ottavi O
    Clin Ter; 1980 Aug; 94(3):283-315. PubMed ID: 7004762
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relation between changes in lipid metabolism and macrocytic anemia in chronic liver disease. Evaluation of therapy with a membranotropic drug].
    De Martiis M; Barlattani A; Parenzi A; Sebastiani F
    Clin Ter; 1984 Oct; 111(2):135-9. PubMed ID: 6239735
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sylimarine in the treatment of chronic hepatitis].
    Sawaryn T; Szymoński K; Machalska M
    Przegl Epidemiol; 1977; 31(4):445-50. PubMed ID: 607279
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O; Trcka V; Vakocová H; Tichý M
    Cas Lek Cesk; 1985 Feb; 124(6):165-9. PubMed ID: 3971403
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Silybin - a prophylactic or curative phalloidin antidote?
    Braatz R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R104. PubMed ID: 1143373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of Amanita phalloides poisoning with silybin in combination with penicillin and cortisone].
    Hofer JF; Egermann G; Mach K; Sommer K
    Wien Klin Wochenschr; 1983 Apr; 95(7):240-3. PubMed ID: 6880207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.